Secondary Renal Investigations for Severe Sodium Sensitivity
In patients with severe sodium sensitivity, perform plasma renin activity (PRA), plasma aldosterone concentration (PAC), and calculate the aldosterone-to-renin ratio to screen for primary aldosteronism, as this condition is present in 8–20% of hypertensive patients and is characterized by suppressed PRA with elevated aldosterone. 1
Initial Diagnostic Workup
Essential Laboratory Tests
Measure serum creatinine, eGFR, and urine albumin-to-creatinine ratio (ACR) in all patients with sodium-sensitive hypertension, as these tests identify renal parenchymal disease and assess for microalbuminuria, which is a marker of cardiovascular risk and correlates strongly with salt sensitivity 1, 2
Obtain 24-hour urine collection for sodium excretion to confirm dietary sodium intake and assess renal sodium handling, as spot urine measurements are unreliable due to measurement bias 3
Check serum electrolytes including potassium, because hypokalemia (though absent in the majority of cases) can indicate mineralocorticoid excess in primary aldosteronism 1
Measure fasting lipid profile including LDL cholesterol, HDL cholesterol, and lipoprotein(a), as salt-sensitive patients display higher levels of atherogenic lipoproteins than salt-resistant patients 2
Screening for Secondary Hypertension
Screen for primary aldosteronism using plasma aldosterone/renin ratio under standardized conditions (correction of hypokalemia and withdrawal of aldosterone antagonists for 4–6 weeks), as this is the most common secondary cause in sodium-sensitive hypertension with a prevalence of 8–20% 1
Perform renal duplex Doppler ultrasound or MRA to evaluate for renovascular disease, particularly in patients with resistant hypertension or abrupt onset/worsening of blood pressure, as renovascular disease has a prevalence of 5–34% in hypertensive populations 1
Obtain thyroid-stimulating hormone (TSH) to exclude hypothyroidism, which can present with sodium-sensitive hypertension 1
Advanced Renal Function Assessment
Glomerular Hemodynamics
Calculate filtration fraction (glomerular filtration rate divided by renal plasma flow) during both low and high sodium intake, as salt-sensitive patients demonstrate increased filtration fraction and elevated intraglomerular pressure with sodium loading, whereas salt-resistant patients do not 2
Measure renal plasma flow during sodium loading, as salt-sensitive patients show decreased renal plasma flow with high sodium intake due to renal vasodysfunction (impaired renal vasodilation and abnormally increased renal vascular resistance) 4, 2
Microalbuminuria Assessment
Quantify urinary albumin excretion on both low and high sodium diets, as salt-sensitive patients display significantly greater albumin excretion (54 ± 11 mg/24h) compared to salt-resistant patients (22 ± 5 mg/24h), and this correlates with glomerular capillary pressure 2
Recognize that microalbuminuria in salt-sensitive patients predicts cardiovascular morbidity and mortality and indicates early renal damage from elevated glomerular capillary pressure 2
Neurohumoral Assessment
Sympathetic Nervous System Evaluation
Measure plasma norepinephrine levels during both low and high sodium intake, as salt-sensitive patients fail to suppress plasma norepinephrine appropriately during high sodium intake (remaining at 20–22 ng/dL) compared to normal suppression in salt-resistant patients (decreasing from 17 to 13 ng/dL) 5
Assess orthostatic plasma norepinephrine response (5-minute standing test), as salt-sensitive patients demonstrate significantly greater increments than salt-resistant patients during both low and high sodium intake, indicating sympathetic nervous system hyperactivity 5
Renin-Angiotensin-Aldosterone System
Measure plasma renin activity and aldosterone during low and high sodium intake to assess suppressibility, though note that impaired RAAS suppression is not the primary mechanism in most salt-sensitive patients 5
Check plasma angiotensin-II levels on day 3 of high sodium intake, as compensatory RAAS activation occurs by this timepoint in response to sodium loading 6
Confirmatory Testing for Primary Aldosteronism
If the aldosterone-to-renin ratio is elevated:
Perform oral sodium loading test (24-hour urine aldosterone with high sodium intake) or IV saline infusion test (plasma aldosterone at 4 hours of infusion) for confirmatory testing 1
Obtain adrenal CT scan to identify aldosterone-producing adenoma or bilateral adrenal hyperplasia 1
Consider adrenal vein sampling to distinguish unilateral from bilateral aldosterone production, as this determines whether surgical versus medical management is appropriate 1
Special Diagnostic Considerations
Insulin Resistance Assessment
Evaluate for insulin resistance and hyperinsulinism, as these are present in a significant percentage of salt-sensitive hypertensive patients and contribute independently to increased cardiovascular risk 7
Measure fasting glucose and consider insulin levels, as insulin resistance correlates with salt sensitivity and microalbuminuria 7
Ambulatory Blood Pressure Monitoring
Perform 24-hour ambulatory blood pressure monitoring to assess dipping status and heart rate, as nondippers with 24-hour heart rate >70 bpm have a 70% prevalence of sodium sensitivity compared to 25% in dippers with heart rate ≤70 bpm 8
Use ABPM data to stratify sodium sensitivity risk: low risk (dippers with HR ≤70 bpm), intermediate risk (mixed pattern), high risk (nondippers with HR >70 bpm) 8
Common Pitfalls to Avoid
Do not rely on spot urine sodium measurements for assessing sodium intake or renal sodium handling, as these have significant measurement bias; always use 24-hour urine collections 3
Do not assume that sodium retention is the mechanism of salt-sensitive hypertension, as most salt-sensitive patients do not have a "natriuretic handicap" and excrete sodium loads at the same rate as salt-resistant subjects 4
Do not overlook renal vasodysfunction as the primary mechanism, as impaired renal vasodilation and abnormally increased renal vascular resistance (not subnormal sodium excretion) are the critical factors initiating salt-induced hypertension in most patients 4
Do not ignore microalbuminuria even when mild, as it is an early sign of renal damage from elevated glomerular capillary pressure and predicts cardiovascular complications 2
Do not miss primary aldosteronism by failing to screen appropriately, as this treatable cause is present in up to 20% of hypertensive patients and is characterized by suppressed renin with elevated aldosterone 1